What is Bactobio?
Headquartered in London, Bactobio operates at the intersection of synthetic biology, next-generation sequencing, and machine learning. The company addresses a fundamental challenge in life sciences: the cultivation of the 99% of microbes that have historically remained unculturable. By accessing an unparalleled bioresource, Bactobio is effectively mapping the hidden chemical and biological landscape of the microbial world.
This capability allows the firm to develop high-value solutions for the pharmaceutical, agricultural, and bioderived-chemical industries. By transforming how these sectors source and develop new products, Bactobio is establishing itself as a foundational player in the bio-economy, moving beyond traditional discovery methods toward a data-driven, scalable model of biological innovation.
How much funding has Bactobio raised?
Bactobio has raised a total of $7.3M across 1 funding round:
Other Financing Round
$7.3M
Other Financing Round (2022): $7.3M with participation from Bridford Group
Key Investors in Bactobio
Bridford Group
Bridford Group is an investment group that deploys its proprietary capital across various sectors, including music, technology, sustainability, lifestyle, and biotech. The company focuses on founder-led businesses with long-term growth potential, primarily in Europe, and emphasizes scalable concepts that contribute positively to society and the environment.
What's next for Bactobio?
With this major strategic investment, Bactobio is poised to scale its research and development infrastructure significantly. The focus will likely shift toward expanding its proprietary bioresource library and deepening the integration of its machine learning algorithms to predict microbial function with greater precision. As the company moves forward, the strategic deployment of this capital will be essential for commercializing its pipeline of novel compounds.
The firm is expected to prioritize partnerships within the pharmaceutical and agricultural sectors, where its unique ability to source previously inaccessible biological data offers a distinct competitive advantage. By maintaining its focus on long-term growth and sustainable innovation, Bactobio is well-positioned to redefine industry standards for microbial discovery and product development.
